Cancer research biotech ImmunSYS files for bankruptcy
The company is a clinical-stage biopharmaceutical firm focused on developing new cancer immunotherapy treatments.
The company is a clinical-stage biopharmaceutical firm focused on developing new cancer immunotherapy treatments.